Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,796.00    -1.00 (-0.06%)
Bid:
1,802.00
Ask:
1,804.00
Spread: 2.00 (0.111%)
Market Cap: £5.74b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Completion of $275m share repurchase programme

22 Dec 2025 07:00

RNS Number : 3632M
Hiscox Ltd
22 December 2025
 

Completion of $275 million share repurchase programme

 

 

Hamilton, Bermuda (22 December 2025) - Hiscox Ltd ("Hiscox" or the "Company") today announces that, further to the share repurchase programme announced on 27 February 2025 to buy back its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $175 million, and subsequently increased on 6 August 2025 to $275 million (the "Programme"), the Company completed the second and final tranche of the Programme on 19 December 2025.

 

Across the Programme the Company purchased 15,894,323 Ordinary Shares between 27 February 2025 and 19 December 2025, pursuant to the agreements with Peel Hunt LLP and Citigroup Global Markets Limited ("Citigroup"), totalling $275.0 million (excluding expenses).

 

Hiscox confirms it has now successfully completed the $275 million Programme.

 

ENDS

 

For further information

 

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

 

Notes to editors

 

About The Hiscox Group

 

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to continue to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

 

The Hiscox Group employs over 3,000 people in 13 countries, and has customers worldwide. Through the retail businesses in the USA, UK and Europe, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

 

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDDUXBDGUC
Date   Source Headline
1st Dec 20212:55 pmRNSTotal Voting Rights
22nd Nov 20219:00 amRNSHiscox appoints new Independent Non Exec Director
18th Nov 20219:00 amRNSHiscox announces Liz Breeze as interim Group CFO
2nd Nov 20217:00 amRNSTrading Statement
1st Nov 202111:12 amRNSTotal Voting Rights
7th Oct 20213:27 pmRNSPDMR Shareholding
4th Oct 20214:10 pmRNSDirector / PDMR Shareholding
1st Oct 20214:52 pmRNSTotal Voting Rights
28th Sep 20213:31 pmRNSDirector/PDMR Shareholding
22nd Sep 20213:14 pmRNSDirector/PDMR Shareholding
20th Sep 202111:40 amRNSApplication to be Admitted to Official List
16th Sep 20215:11 pmRNSDirector / PDMR Shareholding
7th Sep 20215:11 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 202112:57 pmRNSTotal Voting Rights
6th Aug 20212:50 pmRNSTR-1:Standard form - notification major holdings
5th Aug 20212:40 pmRNSTR-1:Standard form notification major shareholding
4th Aug 20214:16 pmRNSTR-1:Standard form notification of major holdings
3rd Aug 20217:01 amRNSInterim Results
3rd Aug 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Aug 20211:53 pmRNSTotal Voting Rights
22nd Jul 20217:00 amRNSAki Hussain to succeed Bronek Masojada as CEO
1st Jul 202112:36 pmRNSTotal Voting Rights
30th Jun 202112:44 pmRNSTR-1 Standard form-notification major shareholding
28th Jun 20215:17 pmRNSResult of Meeting
14th Jun 20211:18 pmRNSDirector/PDMR Shareholding
7th Jun 20211:41 pmRNSTR-1:Standard form notification major shareholding
4th Jun 20212:27 pmRNSDirector/PDMR Shareholding
3rd Jun 20211:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202110:30 amRNSNotice of Meeting
3rd Jun 202110:30 amRNSConsent Solicitation
3rd Jun 20217:00 amRNSLegacy Reinsurance Deal
1st Jun 202111:46 amRNSTotal Voting Rights
14th May 20217:00 amRNSAGM Results
13th May 202112:33 pmRNSSyndicates 33 and 6104 – results and estimates
5th May 20217:00 amRNSTrading Statement
20th Apr 202111:51 amRNSDirector/PDMR Shareholding
16th Apr 202112:47 pmRNSDirector/PDMR Shareholding
13th Apr 202111:41 amRNSNotice of 2021 Annual General Meeting
12th Apr 20212:57 pmRNSDirector/PDMR Shareholding
1st Apr 20213:55 pmRNSTotal Voting Rights
24th Mar 20217:00 amRNSDirector/PDMR Shareholding
22nd Mar 202112:49 pmRNSDirector/PDMR Shareholding
17th Mar 20217:00 amRNS2020 Annual Report
15th Mar 20216:28 pmRNSDirector/PDMR Shareholding
15th Mar 20216:13 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSTR-1:Standard form-notification major shareholding
3rd Mar 20217:01 amRNSFull Year Results
3rd Mar 20217:00 amRNSSyndicates 33 and 6104 – results and estimates
27th Jan 202111:21 amRNSTR-1:Standard form-notification major shareholding
15th Jan 202110:40 amRNSHiscox Ltd response to Supreme Court Judgment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.